- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.10. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.10. | Bluejay Diagnostics completes manufacturing site milestone | 1 | Investing.com | ||
| 13.10. | Bluejay Diagnostics schließt Aufbau von Produktionsstandort ab | 3 | Investing.com Deutsch | ||
| 13.10. | Bluejay Diagnostics: Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness | 333 | ACCESS Newswire | Company Achieves Toray Contractual Milestone with Establishment of Manufacturing Site ACTON, MA / ACCESS Newswire / October 13, 2026 / Bluejay Diagnostics, Inc. (NASDAQ:BJDX) ("Bluejay" or the "Company")... ► Artikel lesen | |
| 06.10. | Bluejay Diagnostics Advances Rapid Biomarker Testing For Sepsis Patients | 1 | Benzinga.com | ||
| 06.10. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.10. | Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock | 386 | ACCESS Newswire | SYMON-II Clinical Validation Dataset Represents a Key Milestone as Bluejay Advances the Symphony IL-6 Test Toward Regulatory Submission ACTON, MA / ACCESS Newswire / October 6, 2026 / Bluejay Diagnostics... ► Artikel lesen | |
| 08.09. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| BLUEJAY DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 08.09. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets | 2 | GlobeNewswire (USA) | ||
| 13.08. | Bluejay Diagnostics reports Q2 results | 1 | Seeking Alpha | ||
| 13.08. | Bluejay Diagnostics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.08. | Bluejay Diagnostics completes enrollment in sepsis test study | 1 | Investing.com | ||
| 13.08. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony IL-6 Toward Regulatory Submission and Commercialization | 495 | GlobeNewswire (Europe) | SYMON-II pivotal clinical study completes targeted enrollment of 750 patientsCompany advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate... ► Artikel lesen | |
| 12.08. | Bluejay Diagnostics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 22.07. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.07. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study | 311 | GlobeNewswire (Europe) | ACTON, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical diagnostics company developing rapid, near-patient diagnostic technologies for critical care, today... ► Artikel lesen | |
| 09.06. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.06. | Bluejay Diagnostics closes $8.5 million private placement | 1 | Investing.com | ||
| 06.06. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules | 1 | GlobeNewswire (USA) | ||
| 03.06. | What's Going On With Bluejay Diagnostics Shares On Wednesday? | 3 | Benzinga.com |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 35,540 | +1,25 % | 12 Prozent bessere Testleistung: Wie ZEISS das Zusammenspiel von Brillenglas und Gehirn untersucht | ||
| TELADOC HEALTH | 5,580 | -1,20 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| HIMS & HERS HEALTH | 25,600 | -1,39 % | Hims & Hers Out with New TRT, Shares Break Even | ||
| SERNOVA BIOTHERAPEUTICS | 0,070 | -1,96 % | Sernova Biotherapeutics mit EILMELDUNG: Könnte die Aktie nach 33,3 % Plus jetzt komplett durchstarten? - Handeln Sie, bevor es zu spät ist! | ||
| CERENOME | 1,470 | +4,11 % | Cerenome, Inc.: Cerenome Announces New Dual Mechanism of Action Featuring Lethal DNA Damage and Beneficial Immunomodulation Supporting Lead Investigational Drug REYOBIQ' | ||
| ATOSSA THERAPEUTICS | 2,460 | +0,82 % | Atossa Therapeutics: Stammaktien handeln ab sofort gekoppelt mit Contingent Value Rights | ||
| GE HEALTHCARE TECHNOLOGIES | 63,50 | -0,27 % | Dividendenbekanntmachungen (23.10.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVANCE AUTO PARTS INC US00751Y1064 0,25 USD EUR ALPHAMIN RESOURCES CORP MU0456S00006 0,13 CAD 0,0827 EUR AMERICAN FINANCIAL GROUP... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 15,500 | 0,00 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,560 | -0,87 % | Joint Venture von Co-Diagnostics zu saudi-arabischem Fertigungsforum eingeladen | ||
| QUIDELORTHO | 12,585 | +4,74 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,240 | -2,18 % | Oppenheimer reiterates Veru stock rating ahead of obesity trial data | ||
| LIFEWARD | 5,880 | -0,51 % | 6,4 Millionen US-Dollar pro Patient: Warum Medtronic, Lifeward und NurExone an drei Stufen der Rückenmarksversorgung ansetzen | ||
| CLOVER HEALTH INVESTMENTS | 4,030 | -4,28 % | Clover Health Investments, Corp.: Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States | ||
| SENSEONICS | 7,250 | +9,85 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen |
Das Unternehmen BLUEJAY DIAGNOSTICS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -7,65 % bei einem Aktienkurs von 0,624 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BLUEJAY DIAGNOSTICS INC finden Sie auf Wallstreet Online.